These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
295 related articles for article (PubMed ID: 10853862)
1. Activation of deltaF508 CFTR in a cystic fibrosis respiratory epithelial cell line by 4-phenylbutyrate, genistein and CPX. Andersson C; Roomans GM Eur Respir J; 2000 May; 15(5):937-41. PubMed ID: 10853862 [TBL] [Abstract][Full Text] [Related]
2. Pharmacological treatment of the ion transport defect in cystic fibrosis. Roomans GM Expert Opin Investig Drugs; 2001 Jan; 10(1):1-19. PubMed ID: 11116277 [TBL] [Abstract][Full Text] [Related]
3. Modulation of deltaF508 cystic fibrosis transmembrane regulator trafficking and function with 4-phenylbutyrate and flavonoids. Lim M; McKenzie K; Floyd AD; Kwon E; Zeitlin PL Am J Respir Cell Mol Biol; 2004 Sep; 31(3):351-7. PubMed ID: 15191910 [TBL] [Abstract][Full Text] [Related]
4. No evidence for direct activation of the cystic fibrosis transmembrane conductance regulator by 8-cyclopentyl-1,3-dipropylxanthine. Kunzelmann K; Briel M; Schreiber R; Ricken S; Nitschke R; Greger R Cell Physiol Biochem; 1998; 8(4):185-93. PubMed ID: 9694345 [TBL] [Abstract][Full Text] [Related]
5. Activation of CFTR by genistein in human airway epithelial cell lines. Andersson C; Servetnyk Z; Roomans GM Biochem Biophys Res Commun; 2003 Aug; 308(3):518-22. PubMed ID: 12914781 [TBL] [Abstract][Full Text] [Related]
6. ERp29 regulates DeltaF508 and wild-type cystic fibrosis transmembrane conductance regulator (CFTR) trafficking to the plasma membrane in cystic fibrosis (CF) and non-CF epithelial cells. Suaud L; Miller K; Alvey L; Yan W; Robay A; Kebler C; Kreindler JL; Guttentag S; Hubbard MJ; Rubenstein RC J Biol Chem; 2011 Jun; 286(24):21239-53. PubMed ID: 21525008 [TBL] [Abstract][Full Text] [Related]
10. A pilot clinical trial of oral sodium 4-phenylbutyrate (Buphenyl) in deltaF508-homozygous cystic fibrosis patients: partial restoration of nasal epithelial CFTR function. Rubenstein RC; Zeitlin PL Am J Respir Crit Care Med; 1998 Feb; 157(2):484-90. PubMed ID: 9476862 [TBL] [Abstract][Full Text] [Related]
11. Defective function of the cystic fibrosis-causing missense mutation G551D is recovered by genistein. Illek B; Zhang L; Lewis NC; Moss RB; Dong JY; Fischer H Am J Physiol; 1999 Oct; 277(4):C833-9. PubMed ID: 10516113 [TBL] [Abstract][Full Text] [Related]
12. Novel amino-carbonitrile-pyrazole identified in a small molecule screen activates wild-type and ΔF508 cystic fibrosis transmembrane conductance regulator in the absence of a cAMP agonist. Namkung W; Park J; Seo Y; Verkman AS Mol Pharmacol; 2013 Sep; 84(3):384-92. PubMed ID: 23788656 [TBL] [Abstract][Full Text] [Related]
13. Correction of G551D-CFTR transport defect in epithelial monolayers by genistein but not by CPX or MPB-07. Zegarra-Moran O; Romio L; Folli C; Caci E; Becq F; Vierfond JM; Mettey Y; Cabrini G; Fanen P; Galietta LJ Br J Pharmacol; 2002 Oct; 137(4):504-12. PubMed ID: 12359632 [TBL] [Abstract][Full Text] [Related]